Advanced Immunological Treatment and Research Medical Center

The History Of Coley’s Toxins

Coleys Toxins

Coley’s ToxinsThe facts are hard to dispute. From 1891-1936 Dr. Coley had a higher success rate treating most cancers than we do today. Over 100 years later, Dr. Coley is considered the father of immunotherapy.Coley’s Toxins Combined With Our Other TreatmentsCHIPSA hospital has been using Coley’s toxins combined with our other immuno-stimulating and detox protocols […]

Continue reading

Rheumatoid Arthritis Treatment: Dramatic Success

Rheumatoid Arthritis Treatment at CHIPSA hospital.Rheumatoid arthritis treatment doesn’t have to be toxic! Instead of beating down the immune system with toxic drugs that have harsh side effects, we use medications that support and stimulate the immune system to have what we call “healing responses”. At CHIPSA hospital we use the following immuno stimulating combination of […]

Continue reading

Ibogaine Treatment Testimonial Fentanyl Patch User

Ibogaine treatment testimonial

Ibogaine Treatment Testimonial from an Eight Year Fentanyl Patch User“I knew deep down in my core that if I could do Ibogaine treatment in a hospital setting with standard protocols it could be safe.”“When I woke up I felt like a new born. My life is back. I feel like myself again. I’m looking forward […]

Continue reading

Cancer Whistle Blower Exposes Cover-Up about Coley’s Toxins

Ralph Moss Cancer Whistle blower Exposes Cover-Up about Coley’s ToxinsAccording to the monographs of Helen Coley Nauts, her fathers “Coley’s Toxins” had a higher success rate in treating cancer patients from 1891-1936, than we have today. She went on to found the Cancer Research Institute in 1953 to study immunlogical treatments for cancer.Ralph Moss was […]

Continue reading

Latest Update on Immunotherapy: Cancer Vaccine

National Cancer Center Singapore [NCCS], released a statement that they will be launching a new therapeutic cancer vaccine treatment. This is a US FDA-approved, human clinical trial for a cancer therapy that is based on the human immune system. The NCCS Trial is significant as it is one of the first trials that is allowed […]

Continue reading

Ovarian Cancer Update: FDA Grants Peptide Vaccine Orphan Status

A substantial breakthrough has taken place in the area of cancer treatment studies for ovarian cancer. New research demonstrates great potential for the immunotherpay DPX-Survivac, used to treat women with ovarian cancer. In early studies, patients exhibited great immune response to the therapy, coupled with a low-dose cyclophosphamide. In turn, the FDA has bestowed an […]

Continue reading

A Woman’s Life is Extended by 9 years Due to Experimental Cancer Therapy

68-year old Sandy Hillburn was one of the university patients who reaped the benefits of experimental cancer therapy. The cancer researchers at Duke University claim that this experimental cancer therapy has helped patients prolong their lives. During an interview, Hillburn stated that she very fortunate to have six grandsons and life-long friends. “I was actually told I […]

Continue reading

Pactomycin analogs offer new, gentler approach to cancer treatment


Kathy Boltz PhD Researchers are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising analogs of an old compound that was once studied as a potent antitumor agent, but long ago abandoned because it was too toxic. Their promising findings were published in PLOS ONE (2015; 10.1371/journal.pone.0125322). The […]

Continue reading
1 12 13 14